In Vivo Evaluation of a Gastro-Resistant HPMC-Based "Next Generation Enteric" Capsule
Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach. However, an enteric formulation is often accompanied with a higher development effort in the first place and the potential degradation of fragile APIs dur...
Saved in:
Main Authors: | Adrian Rump (Author), Marie-Luise Kromrey (Author), Eberhard Scheuch (Author), Vincent Jannin (Author), Lara Rehenbrock (Author), Mladen Vassilev Tzvetkov (Author), Werner Weitschies (Author), Michael Grimm (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vivo Evaluation of a Gastro-Resistant Enprotect<sup>®</sup> Capsule under Postprandial Conditions
by: Michael Grimm, et al.
Published: (2023) -
The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study
by: Adrian Rump, et al.
Published: (2021) -
Comparing Salivary Caffeine Kinetics of <sup>13</sup>C and <sup>12</sup>C Caffeine for Gastric Emptying of 50 mL Water
by: Michael Grimm, et al.
Published: (2023) -
Determination of Gastric Water Emptying in Fasted and Fed State Conditions Using a Compression-Coated Tablet and Salivary Caffeine Kinetics
by: Theodora Tzakri, et al.
Published: (2023) -
In Vitro Evaluation of Enteric-Coated HPMC Capsules-Effect of Formulation Factors on Product Performance
by: Maoqi Fu, et al.
Published: (2020)